Cargando…

Metabolomic Markers for Predicting Preeclampsia in the First Trimester of Pregnancy: A Retrospective Study

We sought to identify the characteristic metabolite profile of blood plasma samples obtained from patients with preeclampsia. Direct high-resolution mass spectrometry was used to analyze samples from 79 pregnant women, 34 of whom had preeclampsia. We performed a comparative analysis of the metabolit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ilgisonis, Ekaterina V., Shalina, Raisa, Kasum-Zade, Nigyar, Burkova, Kristina G., Trifonova, Oxana P., Maslov, Dmitry L., Kaysheva, Anna L., Markin, Sergey S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025490/ https://www.ncbi.nlm.nih.gov/pubmed/35458675 http://dx.doi.org/10.3390/molecules27082475

Ejemplares similares

Metabolomics Community in Russia: History of Development, Key Participants, and Results
por: Balashova, Elena E., et al.
Publicado: (2020)

Current State and Future Perspectives on Personalized Metabolomics
por: Trifonova, Oxana P., et al.
Publicado: (2023)

Personal Metabolomics: A Global Challenge
por: Lokhov, Petr G., et al.
Publicado: (2021)

Metabolome Profiling in Aging Studies
por: Balashova, Elena E., et al.
Publicado: (2022)

Metabolomic Laboratory-Developed Tests: Current Status and Perspectives
por: Lichtenberg, Steven, et al.
Publicado: (2021)

In Situ Mass Spectrometry Diagnostics of Impaired Glucose Tolerance Using Label-Free Metabolomic Signature
por: Lokhov, Petr G., et al.
Publicado: (2020)

Potential Plasma Metabolite Biomarkers of Diabetic Nephropathy: Untargeted Metabolomics Study
por: Trifonova, Oxana P., et al.
Publicado: (2022)

Diagnosis of Parkinson’s Disease by A Metabolomics-Based Laboratory-Developed Test (LDT)
por: Lokhov, Petr G., et al.
Publicado: (2020)

Holistic Metabolomic Laboratory-Developed Test (LDT): Development and Use for the Diagnosis of Early-Stage Parkinson’s Disease
por: Lokhov, Petr G., et al.
Publicado: (2020)

Mass Spectrometry-Based Metabolomics Analysis of Obese Patients’ Blood Plasma
por: Lokhov, Petr G., et al.
Publicado: (2020)

First-Trimester Serum Acylcarnitine Levels to Predict Preeclampsia: A Metabolomics Approach
por: Koster, Maria P. H., et al.
Publicado: (2015)

Evaluation of Dried Blood Spot Sampling for Clinical Metabolomics: Effects of Different Papers and Sample Storage Stability
por: Trifonova, Oxana P., et al.
Publicado: (2019)

Non-Coding RNAs and Prediction of Preeclampsia in the First Trimester of Pregnancy
por: Ogoyama, Manabu, et al.
Publicado: (2022)

Comparative Metabolomic Study of Drosophila Species with Different Lifespans
por: Maslov, Dmitry L., et al.
Publicado: (2021)

Usefulness of circulating microRNAs for the prediction of early preeclampsia at first-trimester of pregnancy
por: Luque, Ana, et al.
Publicado: (2014)

Defining Blood Plasma and Serum Metabolome by GC-MS
por: Kiseleva, Olga, et al.
Publicado: (2021)

n-Butylamine for Improving the Efficiency of Untargeted Mass Spectrometry Analysis of Plasma Metabolite Composition
por: Maslov, Dmitry L., et al.
Publicado: (2019)

Interstitial Pregnancy in the Third Trimester with Severe Preeclampsia: A Case Report and Literature Review
por: Nagayama, Shiho, et al.
Publicado: (2020)

Blood Plasma Metabolome Profiling at Different Stages of Renal Cell Carcinoma
por: Maslov, Dmitry L., et al.
Publicado: (2022)

First Trimester Urine and Serum Metabolomics for Prediction of Preeclampsia and Gestational Hypertension: A Prospective Screening Study
por: Austdal, Marie, et al.
Publicado: (2015)

Differences in maternal soluble ST2 levels in the third trimester of normal pregnancy versus preeclampsia
por: Sasmaya, Prameswari Hawani, et al.
Publicado: (2021)

Cell Proteomic Footprinting: Advances in the Quality of Cellular and Cell-Derived Cancer Vaccines
por: Lokhov, Petr G., et al.
Publicado: (2023)

Analysis of the Placental Tissue Transcriptome of Normal and Preeclampsia Complicated Pregnancies
por: Trifonova, E. A., et al.
Publicado: (2014)

Evaluation of first- and third-trimester afamin levels in preeclampsia
por: Gülücü, Selim, et al.
Publicado: (2023)

Analysis of sequential hair segments reflects changes in the metabolome across the trimesters of pregnancy
por: Delplancke, Thibaut D. J., et al.
Publicado: (2018)

Quantitative Proteomic (iTRAQ) Analysis of 1st Trimester Maternal Plasma Samples in Pregnancies at Risk for Preeclampsia
por: Kolla, Varaprasad, et al.
Publicado: (2012)

Utility of a single mid-trimester measurement of plasminogen activator Type 1 and fibronectin to predict preeclampsia in pregnancy
por: Ajibola, S. O., et al.
Publicado: (2016)

Gut microbiota dysbiosis in preeclampsia patients in the second and third trimesters
por: Wang, Jing, et al.
Publicado: (2020)

Is the First-Trimester Systemic Immune-Inflammation Index Associated With Preeclampsia?
por: Cevher Akdulum, Munire Funda, et al.
Publicado: (2023)

Reviewing Accuracy of First Trimester Screening for Preeclampsia Using Maternal Factors and Biomarkers
por: Malone, Sarah L, et al.
Publicado: (2022)

“Abnormal Analyte Preeclampsia”: Do the second trimester maternal serum analytes help differentiate preeclampsia subtypes?
por: CRITCHFIELD, Agatha S, et al.
Publicado: (2013)

Management of a Splenic Artery Aneurysm in the Third Trimester of Pregnancy
por: Zarudskaya, Oxana, et al.
Publicado: (2020)

A Metabolomics Approach to Pharmacotherapy Personalization
por: Balashova, Elena E., et al.
Publicado: (2018)

Diagnosing Impaired Glucose Tolerance Using Direct Infusion Mass Spectrometry of Blood Plasma
por: Lokhov, Petr G., et al.
Publicado: (2014)

Adiposity and hyperleptinemia during the first trimester among pregnant women with preeclampsia
por: Yeboah, Francis Agyemang, et al.
Publicado: (2017)

Integrating Combined First Trimester Screening for Preeclampsia into Routine Ultrasound Examination
por: Trottmann, Fabienne, et al.
Publicado: (2022)

Results of a Five-Year Experience in First Trimester Preeclampsia Screening
por: Capriglione, Stella, et al.
Publicado: (2022)

Effects of maternal characteristics and medical history on first trimester biomarkers for preeclampsia
por: Torres-Torres, Johnatan, et al.
Publicado: (2023)

First-trimester preeclampsia screening and prevention: impact on patient satisfaction and anxiety
por: Silang, Katherine, et al.
Publicado: (2023)

Screening for Preeclampsia in the First Trimester and Aspirin Prophylaxis: Our First Year
por: Lourenço, Inês, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0fnuhhcg9tslo5oqbrlappvb73